Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

FDA approves Novartis' Xolair for Rare Skin Disease

March 24, 2014

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

XstalBio Launches Vaccine Analysis Service

March 24, 2014

XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.

Texas A&M Center Adds Mobile Cleanrooms

March 13, 2014

Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.

Almac Expands Asia Pacific Operations

March 12, 2014

Almac expands technical, project, and operational resources in Asia.

DPx Launched as Provider of Pharmaceutical Services, Fine Chemicals, and Proprietary Technologies

March 12, 2014

$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.

Johnson Controls Launches Integrated Laboratory Services

March 7, 2014

Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.

Cobra Biologics and BioCancell Collaborate on Cancer Therapy Drug

March 7, 2014

Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.

CPhI Report Shows R&D Market Diversifying

March 7, 2014

CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.

Waters Marks Ten Years of ACQUITY UPLC With the Introduction of New Products

March 4, 2014

Waters celebrates ten&$45;year anniversary of the ACQUITY UPLC System.

ADVERTISEMENT

ADVERTISEMENT

Click here